RS54736B1 - Postupak za sintezu derivata 3,6-dihidro-1,3,5-triazina - Google Patents

Postupak za sintezu derivata 3,6-dihidro-1,3,5-triazina

Info

Publication number
RS54736B1
RS54736B1 RS20160296A RSP20160296A RS54736B1 RS 54736 B1 RS54736 B1 RS 54736B1 RS 20160296 A RS20160296 A RS 20160296A RS P20160296 A RSP20160296 A RS P20160296A RS 54736 B1 RS54736 B1 RS 54736B1
Authority
RS
Serbia
Prior art keywords
compound
formula
process according
butanol
solvent
Prior art date
Application number
RS20160296A
Other languages
English (en)
Serbian (sr)
Inventor
Stéphanie AUBOURG
Bernard Boudet
Daniel Cravo
Matthias Helmreich
Original Assignee
Poxel Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poxel Sas filed Critical Poxel Sas
Publication of RS54736B1 publication Critical patent/RS54736B1/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D251/00Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/10Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
RS20160296A 2008-05-23 2009-04-24 Postupak za sintezu derivata 3,6-dihidro-1,3,5-triazina RS54736B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08009483 2008-05-23
PCT/EP2009/002997 WO2009141040A2 (en) 2008-05-23 2009-04-24 Process for the synthesis of 3,6-dihydro-1,3,5-triazine derivatives
EP09749530.3A EP2300444B1 (en) 2008-05-23 2009-04-24 Process for the synthesis of 3,6-dihydro-1,3,5-triazine derivatives

Publications (1)

Publication Number Publication Date
RS54736B1 true RS54736B1 (sr) 2016-10-31

Family

ID=40791625

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20160296A RS54736B1 (sr) 2008-05-23 2009-04-24 Postupak za sintezu derivata 3,6-dihidro-1,3,5-triazina

Country Status (21)

Country Link
US (1) US20110124860A1 (enExample)
EP (1) EP2300444B1 (enExample)
JP (1) JP5458093B2 (enExample)
KR (1) KR101618198B1 (enExample)
CN (1) CN102036970A (enExample)
AU (1) AU2009250149B2 (enExample)
BR (1) BRPI0912512B1 (enExample)
CA (1) CA2725011A1 (enExample)
CY (1) CY1117855T1 (enExample)
DK (1) DK2300444T3 (enExample)
EA (1) EA018921B1 (enExample)
ES (1) ES2571793T3 (enExample)
HR (1) HRP20160414T1 (enExample)
HU (1) HUE027532T2 (enExample)
IL (1) IL209198A (enExample)
MX (1) MX2010012741A (enExample)
PL (1) PL2300444T3 (enExample)
RS (1) RS54736B1 (enExample)
SI (1) SI2300444T1 (enExample)
WO (1) WO2009141040A2 (enExample)
ZA (1) ZA201009160B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2646422T3 (pl) 2010-12-01 2015-12-31 Poxel Rozdział enancjomerów pochodnych triazyny z zastosowaniem kwasu winowego
CN105753801B (zh) * 2016-03-25 2018-06-01 浙江工业大学 一种均三嗪类化合物的制备方法
JP2020536121A (ja) 2017-10-02 2020-12-10 ポクセルPoxel 駆出率が保持された心不全を治療する方法
CA3102412A1 (en) 2018-06-06 2019-12-12 Metavant Sciences Gmbh Methods of treating subjects having diabetes with chronic kidney disease
WO2019238647A1 (en) 2018-06-14 2019-12-19 Poxel Film-coated tablet comprising a triazine derivative for use in the treatment of diabetes
CN114681464B (zh) * 2020-12-28 2024-07-09 南京理工大学 二甲双胍类似物在制备脑缺血再灌注损伤预防和治疗药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2804113B1 (fr) * 2000-01-26 2004-06-18 Lipha Derives animes de dihydro-1,3,5-triazine et leurs applications en therapeutique
AU2003289375A1 (en) * 2002-12-17 2004-07-09 Hamari Chemicals, Ltd Novel 2,4-diamino-1,3,5-triazine derivative
FR2853650B1 (fr) * 2003-04-10 2006-07-07 Merck Sante Sas Procede de dedoublement d'amines utiles pour le traitement de desordres associes au syndrome d'insulino-resistance
DE102007054416A1 (de) * 2007-11-13 2009-05-14 Studiengesellschaft Kohle Mbh Verfahren zur Herstellung von 3,6-Dihydro-1,3,5- Triazin-Derivaten für die Behandlungen von Erkrankungen, die mit dem Insulinresistenz-Syndrom assoziiert sind

Also Published As

Publication number Publication date
WO2009141040A2 (en) 2009-11-26
PL2300444T3 (pl) 2016-08-31
JP2011520930A (ja) 2011-07-21
SI2300444T1 (sl) 2016-10-28
WO2009141040A3 (en) 2010-01-21
MX2010012741A (es) 2010-12-21
KR101618198B1 (ko) 2016-05-04
AU2009250149A1 (en) 2009-11-26
EA201001828A1 (ru) 2011-04-29
JP5458093B2 (ja) 2014-04-02
BRPI0912512B1 (pt) 2018-09-11
EP2300444A2 (en) 2011-03-30
DK2300444T3 (en) 2016-05-23
IL209198A0 (en) 2011-01-31
CN102036970A (zh) 2011-04-27
CA2725011A1 (en) 2009-11-26
KR20110013498A (ko) 2011-02-09
EA018921B1 (ru) 2013-11-29
US20110124860A1 (en) 2011-05-26
HUE027532T2 (en) 2016-10-28
EP2300444B1 (en) 2016-04-13
HRP20160414T1 (hr) 2016-05-20
CY1117855T1 (el) 2017-05-17
BRPI0912512A2 (pt) 2015-07-28
ES2571793T3 (es) 2016-05-26
AU2009250149B2 (en) 2013-05-23
IL209198A (en) 2013-11-28
ZA201009160B (en) 2011-10-26

Similar Documents

Publication Publication Date Title
RS54736B1 (sr) Postupak za sintezu derivata 3,6-dihidro-1,3,5-triazina
KR101891933B1 (ko) B형 간염 바이러스 감염의 치료 또는 예방을 위한 신규한 피리다존 및 트라이아진온
TR201802913T4 (tr) Yeni 4,6-çift ikameli aminopirimidin türevleri.
KR20120098815A (ko) 메틸-{4,6-디아미노-2-[1-(2-플루오로벤질)-1h-피라졸로[3,4-b]피리디노-3-일]피리미디노-5-일}카르바메이트의 제조 방법 및 제약 물질로서의 그의 사용을 위한 그의 정제
Bharti et al. Diversity oriented synthesis of tri-substituted methane containing aminouracil and hydroxynaphthoquinone/hydroxycoumarin moiety using organocatalysed multicomponent reactions in aqueous medium
JP4432492B2 (ja) 4−イミダゾリン−2−オン化合物
TW201144298A (en) Heterocyclic antiviral compounds
Correia et al. Synthesis and in vitro activity of 6-amino-2, 9-diarylpurines for Mycobacterium tuberculosis
WO2007035010A2 (en) 5,6-dimethylthieno[2,3-di] pyrimidine derivatives, the preparation method thereof and the pharmaceutical composition comprising the same for anti-virus
Vitale et al. 2-Arylbenzimidazoles as antiviral and antiproliferative agents-Part 1
Wada et al. A Facile Synthesis of 2, 4-Disubstituted 3-Fluoroquinolines via Intramolecular Cyclization of o-Cyanomethylamino-β, β-difluorostyrenes
CN102399197B (zh) 2-(2-羟基-2-取代苯乙基硫基)-3h-嘧啶-4-酮类化合物及其合成方法与用途
Gosavi et al. Design, Synthesis, Characterization and Biological Evaluation of Novel Thiazolidine-4-Ones
EP2630130A1 (en) Method for preparing substituted n-(3-amino-quinoxalin-2-yl)-sulfonamides and their intermediates n-(3-chloro-quinoxalin-2-yl)sulfonamides
Dabak et al. Synthesis of 1-vinyl 1, 2, 3-triazole derivatives
Meng et al. Design, synthesis and antitumor activity of pyrrolopyrazinone-chalcone hybrids
JP2004339210A (ja) p38MAPキナーゼ阻害剤
Hassan et al. Synthesis and Characterization of Some New 2, 4-Thiazolidinedione Derivatives
Khodairy et al. 1442 One-Pot Multicomponent Synthesis of Novel 2-Tosyloxyphenylpyrans under Green and Conventional Condition with Anti-inflammatory Activity
JPS6081173A (ja) ジヒドロピリミジン誘導体およびその製造法
Mesropyan et al. Synthesis of 3-Allyloxy (2-hydroxypropyl)-5, 5-dimethylhydantoin, 1-Allyloxy (2-hydroxypropyl)-substituted Benzotriazole and Benzimidazole, and N-allyloxy (2-hydroxypropyl)-substituted Pyrrolidone, Caprolactam, and Phthalimide
KOTB et al. EFFICIENT SYNTHESIS AND MOLECULAR MODELING OF NEW N-/S-NUCLEOSIDES AND SCHIFF, S BASES OF TETRAHYDROPYRIMIDINE SCAFFOLD AS POTENTIAL H5N1 AVIAN INFLUENZA A VIRUS INHIBITORS
Tang Reaction of pyrimidine-4, 6-diol with aldehydes under microwave irradiation
CZ146998A3 (cs) Způsob přípravy 2H-1-benzopyranu
HK1239677B (en) Methods of preparing toll-like receptor modulators